Gene · 776
Papers2,356
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,356
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Patient-Specific iPSCs-Based Models of Neurodegenerative Diseases: Focus on Aberrant Calcium Signaling. | Int J Mol Sci | 2022 | 35054808 | PubTator, text mining | PubMed |
| How to Explore an Endocrine Cause of Hypertension. | J Clin Med | 2022 | 35054115 | PubTator, text mining | PubMed |
| Deletion of the voltage-gated calcium channel, CaV 1.3, causes deficits in motor performance and associative learning. | Genes Brain Behav | 2022 | 35044095 | PubTator, text mining | PubMed |
| Identification of Sclareol As a Natural Neuroprotective Cav 1.3-Antagonist Using Synthetic Parkinson-Mimetic Gene Circuits and Computer-Aided Drug Discovery. | Adv Sci (Weinh) | 2022 | 35040584 | PubTator, text mining | PubMed |
| A Pro-Endocrine Pancreatic Islet Transcriptional Program Established During Development Is Retained in Human Gallbladder Epithelial Cells. | Cell Mol Gastroenterol Hepatol | 2022 | 35032693 | PubTator, text mining | PubMed |
| Visualization of calcium channel blockers in human adrenal tissues and their possible effects on steroidogenesis in the patients with primary aldosteronism (PA). | J Steroid Biochem Mol Biol | 2022 | 35031428 | PubTator, text mining | PubMed |
| Calcium selective channel TRPV6: Structure, function, and implications in health and disease. | Gene | 2022 | 35031425 | PubTator, text mining | PubMed |
| A Matrigel-based 3D construct of SH-SY5Y cells models the α-synuclein pathologies of Parkinson's disease. | Dis Model Mech | 2022 | 35023548 | PubTator, text mining | PubMed |
| Comprehensive exploration of the genetic contribution of the dopaminergic and serotonergic pathways to psychiatric disorders. | Transl Psychiatry | 2022 | 35013130 | PubTator, text mining | PubMed |
| Dual effect of nifedipine on pregnant human myometrium contractility: Implication of TRPC1. | J Cell Physiol | 2022 | 34988986 | PubTator, text mining | PubMed |
| The Impact of Donor and Recipient Genetic Variation on Outcomes After Solid Organ Transplantation: A Scoping Review and Future Perspectives. | Transplantation | 2022 | 34974452 | PubTator, text mining | PubMed |
| Region-specific distribution of transversal-axial tubule system organization underlies heterogeneity of calcium dynamics in the right atrium. | Am J Physiol Heart Circ Physiol | 2022 | 34951544 | PubTator, text mining | PubMed |
| Reviving Cav1.2 as an attractive drug target to treat bladder dysfunction. | FASEB J | 2022 | 34939692 | PubTator, text mining | PubMed |
| Mechanisms and physiological implications of cooperative gating of clustered ion channels. | Physiol Rev | 2022 | 34927454 | PubTator, text mining | PubMed |
| Investigating Genetic Mutations in a Large Cohort of Iranian Patients with Congenital Hyperinsulinism | J Clin Res Pediatr Endocrinol | 2022 | 34927408 | PubTator, text mining | PubMed |
| Mechanisms of Sinoatrial Node Dysfunction in Heart Failure With Preserved Ejection Fraction. | Circulation | 2022 | 34905696 | PubTator, text mining | PubMed |
| Requirement of Cavin-2 for the expression and stability of IRβ in adequate adipocyte differentiation. | Mol Metab | 2022 | 34896640 | PubTator, text mining | PubMed |
| Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity. | Mol Oncol | 2022 | 34792282 | PubTator, text mining | PubMed |
| Salinomycin as a potent anticancer stem cell agent: State of the art and future directions. | Med Res Rev | 2022 | 34786735 | PubTator, text mining | PubMed |
| Dietary, Cultural, and Pathogens-Related Selective Pressures Shaped Differential Adaptive Evolution among Native Mexican Populations. | Mol Biol Evol | 2022 | 34597392 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/776/papers?page=33